Publications

Publications from the ASID CRN

1. Blyth C. Walls T., Cheng A., Murray R., Fisher D., Ingram P., Davis J. A comparison of paediatric and adult infectious diseases consultations in Australia and New Zealand. European Journal of Clinical Microbiology & Infectious Diseases. 2015 April ahead of print.

2. Rogers BA, Ingram PR, Runnegar N, Pitman MC, Freeman JT, Athan E, Havers S, Sidjabat HE, Gunning E, De Almeida M, Styles K, Paterson DL; ASID CRN. Sequence type 131 fimH30 and fimH41 subclones amongst Escherichia coli isolates in Australia and New Zealand. International Journal of Antimicrobial Agents. 2015 Apr; 45(4):351-8. Epub 2015 Jan 13.

3. Harris PN, Peleg AY, Iredell J, Ingram PR, Miyakis S, Stewardson AJ, Rogers BA, McBryde ES, Roberts JA, Lipman J, Athan E, Paul SK, Baker P, Harris-Brown T, Paterson DL. Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli and Klebsiella spp (the MERINO trial): study protocol for a randomised controlled trial. Trials. 2015 Jan 27; 16(1):24.

4. Ingram PR, Cheng AC, Murray RJ, Blyth CC, Walls T, Fisher DA, Davis JS; Australasian Society for Infectious Diseases Clinical Research Network. What do infectious diseases physicians do? A 2-week snapshot of inpatient consultative activities across Australia, New Zealand and Singapore. Clinical Microbiology and Infection. 2014 Oct; 20(10):O737-44. Epub 2014 Mar 6.

5. Rogers BA, Ingram PR, Runnegar N, Pitman MC, Freeman JT, Athan E, Havers SM, Sidjabat HE, Jones M, Gunning E, De Almeida M, Styles K, Paterson DL; Australasian Society for Infectious Diseases Clinical Research Network. Community-onset Escherichia coli infection resistant to expanded-spectrum cephalosporins in low-prevalence countries. Antimicrobial Agents Chemotherapy. 2014; 58(4):2126-34. Epub 2014 Jan 27.

6. Paterson DL; Steering Group of the Australasian Society for Infectious Diseases Clinical Research Network. Determining research priorities for clinician-initiated trials in infectious diseases. Medical Journal of Australia. 2013 Mar 18; 198(5):270-2.

7. Joshua S. Davis, Archana Sud, Matthew V. N. O'Sullivan, James O. Robinson, Patricia E. Ferguson, Hong Foo, Sebastiaan J. van Hal, Anna P. Ralph, Benjamin P. Howden, Paula M. Binks, Adrienne Kirby, Steven Y. C. Tong,
for the Combination Antibiotics for MEthicillin Resistant Staphylococcus aureus (CAMERA) study groupb
the Australasian Society for Infectious Diseases Clinical Research Network, Combination of Vancomycin and β-Lactam Therapy for Methicillin-Resistant Staphylococcus aureus Bacteremia: A Pilot Multicenter Randomized Controlled Trial. Oct 2015

Publications from the ASID CRN in collaboration with other groups

1. Dulhunty JM, Roberts JA, Davis JS, Webb SA, Bellomo R, Gomersall C, Shirwadkar C, Eastwood GM, Myburgh J, Paterson DL, Starr T, Udy AA, Paul SK, Lipman J; Australian and New Zealand Intensive Care Society Clinical Trials Group; Australasian Society for Infectious Diseases Clinical Research Network. A protocol for a multicentre randomised controlled trial of continuous beta-lactam infusion compared with intermittent beta-lactam dosing in critically ill patients with severe sepsis: the BLING II study. Critical Care and Resuscitation. 2013 Sep; 15(3):179-85.

2. Dulhunty JM, Roberts JA, Davis JS, Webb SA, Bellomo R, Gomersall C, Shirwadkar C, Eastwood GM, Myburgh J, Paterson DL, Lipman J. Continuous infusion of beta-lactam antibiotics in severe sepsis: a multicenter double-blind, randomized controlled trial. Clinical Infectious Diseases. 2013 Jan; 56(2):236-44. Epub 2012 Oct 16.

3. ANZIC Influenza Investigators, Webb SA, Pettilä V, Seppelt I, Bellomo R, Bailey M, Cooper DJ, Cretikos M, Davies AR, Finfer S, Harrigan PW, Hart GK, Howe B, Iredell JR, McArthur C, Mitchell I, Morrison S, Nichol AD, Paterson DL, Peake S, Richards B, Stephens D, Turner A, Yung M. Critical care services and 2009 H1N1 influenza in Australia and New Zealand. The New England Journal of Medicine. 2009 Nov 12; 361(20):1925-34. Epub 2009 Oct 8.